Filing volume digest
Wednesday, Nov 4, 2026 (full day, per the EDGAR daily index): Reg D: 189 new Form D and 130 D/A filings. Reg CF: 1 new Form C (Solar Development Group LLC), 2 C/A (Satschel, Inc.), 2 C-U progress updates (Hawaiian Ola Brewing, Shippy Nation), 1 C-W withdrawal (Sparrow Vision) and 5 C-AR annual reports (Coco Nation, For Sure Nation, Valance Nation, W Motorhome Sales North America and ZeroT24 Nation). Reg A: no new Form 1-A; 1 1-A/A (Doroni Aerospace), 2 1-A POS (Modern Mining Technology, Tirios Propco Series), 1 1-K annual report (IdentifySensors Biologics) and 1 1-U current report (AtomBeam Technologies).
After 5 PM ET Wednesday through about 7 AM Thursday (EDGAR live feed): 50 more Form D and 9 D/A filings. AI3 Bio filed a $48.3M post-merger equity round and Vuelta Holdings reported $443M sold to one investor. The largest figures, Andersen Aggregator and AT Umbrella at $1.92B each, come from an internal reorganization with no cash paid. Barington Companies Equity Partners updated its hedge fund at $209.5M sold to 154 investors, and a wave of small Rule 506(b) venture SPVs from roll-up and angel-fund platforms filed overnight. No new Reg CF or Reg A filings overnight. Offering amounts are maximums, not money raised.
Thursday, about 7 to 8:10 AM ET (EDGAR live feed): A quiet open, with 1 new Form D and 2 D/A filings. MCP Emerging Markets LLP, a London fund, amended its notice to report $52.5M sold to 4 investors with a $1M minimum, and Metari Technologies, a London environmental services company, updated an $8.08M equity raise that reports about $12,800 sold. VERTEXDE Ltd of Denver filed a new notice reporting $100M sold to 10,000 investors with a first sale dated today, figures that are unusual for a first filing. No new Reg A, Form C or C-AR filings in this window. Offering amounts are maximums, not money raised.
Thursday, about 8:10 to 9:05 AM ET (EDGAR live feed): 5 new Form D filings and no D/A, Reg A, Form C or C-AR activity. WG Wayzata DST, a Bloomington, Minnesota commercial Delaware statutory trust sponsored by Exchange Realty, filed a first-time notice for an $11.1 million Rule 506(c) equity offering, reporting $1.31 million sold to 2 investors with a $50,000 minimum and Metric Financial listed for sales compensation. Four small Claymont, Delaware series LLC vehicles tied to the CGF platform also filed fully sold Rule 506(b) notices between $37,000 and $61,500 (FLI 10267, WTI 1026, MOE Collective Enterprise and Mom Snacks Apr 2025). Offering amounts are maximums, not money raised.
Thursday, about 9:05 to 10:05 AM ET (EDGAR live feed): 20 new Form D and 11 D/A filings, with no Reg A, Form C or C-AR activity. GOA Therapeutics, whose DealMaker-led Reg A offering was qualified on October 13, filed a $225 million Rule 506(c) equity raise with $300,000 sold. Clarion Alternative Sectors Fund updated its notice at $1.18 billion sold to 42 investors, JP Solidarity Impact Fund reported $78.4 million sold, and Pelorus Growth Fund kept a $1 billion Rule 506(c) offering open at $3.58 million sold. Stealth Critical Metals of Houston reported a fully sold $6.5 million round, BlueArc’s Montage Investment series reported $24.9 million from 93 investors, and another 10 small CGF-platform and angel SPV series filed fully sold notices. Offering amounts are maximums, not money raised.
Spotlight
Newly qualified Reg A issuer GOA Therapeutics files a $225M Rule 506(c) raise
Form D (new) · Rule 506(c) · Pharmaceuticals · Equity · $225M offering, $300,000 sold · 1 investor · $750 minimum · First sale Oct 22, 2026 · West Palm Beach, FL · Filed Nov 5, 2026
GOA Therapeutics Corp, a West Palm Beach, Florida pharmaceutical company incorporated in 2024, filed its first Form D on Thursday morning for a $225 million Rule 506(c) equity offering, reporting $300,000 sold to 1 investor with a $750 minimum and a first sale dated October 22, 2026. The notice lands weeks after the SEC qualified the company’s Regulation A offering on October 13, which its amended offering statement describes as up to 5 million common shares at $15 each, with DealMaker Securities LLC listed as underwriter. Andrew Altschuler signed as chief executive officer, and the company reports no revenue.
Health care is running the hottest of any sector versus the overall market’s tone today, even as the Market Mood Index sits in Anxiety. Pairing a newly qualified Reg A offering with a Rule 506(c) notice lets a company market to retail and accredited investors on separate tracks; the $225M figure is a maximum, and only $300,000 is reported sold.
Clarion Alternative Sectors Fund updates its notice at $1.18B sold
Form D/A · Rule 506(b), 3(c)(7) · Pooled investment fund · Indefinite offering, $1.18B sold · 42 investors · First sale Nov 20, 2025 · New York, NY · Filed Nov 5, 2026
Clarion Alternative Sectors Fund, LP, a New York pooled investment fund whose general partner is controlled by Clarion Partners, LLC, filed its annual Form D amendment on Thursday reporting $1.18 billion sold to 42 investors in an open-ended Rule 506(b) offering. The original notice was filed in November 2025, with a first sale dated November 20, 2025. David J. Gilbert is listed as chief executive officer of Clarion Partners.
Real estate sentiment is running warmer than the overall market today. An average commitment of roughly $28 million per investor points to institutional and large family-office capital rather than individual accredited investors.
Pelorus Growth Fund keeps a $1B Rule 506(c) offering open with $3.58M sold
Form D/A · Rule 506(c) · Other · Equity · $1B offering, $3.58M sold · 48 investors · $50,000 minimum · First sale Sep 3, 2025 · Newport Beach, CA · Filed Nov 5, 2026
Pelorus Growth Fund, LLC of Newport Beach, California filed a Form D amendment on Thursday for its $1 billion Rule 506(c) equity offering, reporting $3.58 million sold to 48 investors with a $50,000 minimum. The first sale is dated September 3, 2025, and Daniel A. Leimel, Jr. and James Robert Sechrist are named as executive officers and directors.
A large headline maximum with modest sales is common for Rule 506(c) vehicles that advertise to accredited investors over a long period. The Market Mood Index remains in Anxiety, which tends to slow retail-facing private raises.
WG Wayzata DST files an $11.1M Rule 506(c) commercial real estate raise
Form D (new) · Rule 506(c) · Commercial · Equity · $11.10M offering, $1.31M sold · 2 investors · $50,000 minimum · First sale Nov 4, 2026 · Metric Financial, LLC (sales compensation) · Bloomington, MN · Filed Nov 5, 2026
WG Wayzata DST, a Bloomington, Minnesota Delaware statutory trust sponsored by Exchange Realty, Inc., filed a first-time Form D on Thursday morning for an $11.1 million Rule 506(c) equity offering, reporting $1.31 million sold to 2 investors with a $50,000 minimum and a first sale dated November 4, 2026. Metric Financial, LLC is listed for sales compensation with an estimated $881,051 in commissions, and Duane H. Lund is named as manager of the signatory trustee.
Real estate sentiment is running warmer than the overall market (Optimism on the sector read), even as the Market Mood Index remains in Anxiety. Rule 506(c) lets issuers advertise to accredited investors, a structure often used for DST and other commercial property vehicles.
AI3 Bio files a $48.3M post-merger equity round
Form D (new) · Rule 506(b) · Biotechnology · Equity · $48.34M offering, fully sold · 8 investors · First sale Jun 9, 2026 · Watertown, MA · Filed Nov 4, 2026
AI3 Bio, Inc., a Watertown, Massachusetts biotechnology company, filed a first-time Form D on Wednesday evening reporting a $48.3 million equity financing fully sold to 8 investors, with the first sale dated June 9, 2026. The filing says the round was completed after a merger and that the shares were not issued in the merger itself. Steven Altschuler and Alan Ezekowitz are among the people named, and a second notice filed minutes later lists an open-ended offering with no further sales yet.
Health care is one of the sectors where investor sentiment is running hotter than the overall market, and sentiment on biotech stocks has improved over the past month. Deal chatter is helping: AstraZeneca was reported this week to have approached Rhythm Pharmaceuticals at about $10 billion.
Recent Annual Reports (Form C-AR)
ZeroT24 Nation LLC
Filed 2026-11-04 · FY 2025 · ALAO Invest LLC
- Revenue
- $0
- Net income
- -$90.3K
- Total assets
- $183.6K
- Employees
- 0
ZeroT24 Nation LLC filed its annual report reporting revenue of $0 and a net loss of $90.3K for fiscal year 2025, with $183.6K in total assets and 0 employees.
View on EDGAR →
Coco Nation LLC
Filed 2026-11-04 · FY 2025 · ALAO Invest LLC
- Revenue
- $231
- Net income
- -$67.4K
- Total assets
- $118.9K
- Employees
- 0
Coco Nation LLC filed its annual report reporting revenue of $231 and a net loss of $67.4K for fiscal year 2025, with $118.9K in total assets and 0 employees.
View on EDGAR →
Valance Nation LLC
Filed 2026-11-04 · FY 2025 · ALAO Invest LLC
- Revenue
- $0
- Net income
- -$45.5K
- Total assets
- $59.6K
- Employees
- 0
Valance Nation LLC filed its annual report reporting revenue of $0 and a net loss of $45.5K for fiscal year 2025, with $59.6K in total assets and 0 employees.
View on EDGAR →
For Sure Nation LLC
Filed 2026-11-04 · FY 2025 · ALAO Invest LLC
- Revenue
- $217
- Net income
- -$49.2K
- Total assets
- $82.8K
- Employees
- 0
For Sure Nation LLC filed its annual report reporting revenue of $217 and a net loss of $49.2K for fiscal year 2025, with $82.8K in total assets and 0 employees.
View on EDGAR →
W Motorhome Sales North America, Inc.
Filed 2026-11-04 · FY 2025
- Revenue
- $153.4K
- Net income
- -$143.9K
- Total assets
- $1.5M
- Employees
- 3
W Motorhome Sales North America, Inc. filed its annual report reporting revenue of $153.4K and a net loss of $143.9K (vs a $234.2K loss the prior year) for fiscal year 2025, with $1.5M in total assets and 3 employees.
View on EDGAR →
Data generated: 2026-11-05T15:08:26Z
